Delivery Order SPE2DB24D1205-SPE2DB24FCSCZ

Award Date 6/18/24
Potential Completion Date 7/11/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of KEDRAB, a 300 unit/2 ml vial medication. The $3,990.36 firm fixed price delivery order contract has a completion date of June 25, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of KEDRAB, a 1,500 unit/10 ml vial of this pharmaceutical product. The $6,497.52 Firm Fixed Price contract was awarded on June 24, 2024 by the U.S. Department of Defense's Medical Supply Chain agency, with a completion date of July 16, 2024. The contract is a Delivery Order with no set-aside designation. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,253.40, is for the supply of 1,500 units of the medication KEDRAB, a 10 ML vial. The contract has a firm fixed price pricing type and a period of performance through April 11, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.70 delivery order contract is for the supply of KEDRAB, a 1,500 unit/10 ML vial medication, with a performance period ending on April 24, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KEDRAB, a 1,500 unit/10 ml vial of a pharmaceutical product. The contract has a ceiling value of $1,626.70 and is a firm fixed price, non-set-aside contract with a performance period ending on May 19, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite...
This is a $9,760.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,500 units of the pharmaceutical product KEDRAB, a 10 mL vial, with a period of performance through February 28, 2025. The contract was not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical,...
This is a $11,673.36 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of KEDRAB 150 U/ML medication vials, with a period of performance through October 8, 2024. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and...
This is a $13,633.73 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of April 29, 2025, is for the supply of KEDRAB 150 U/ML VL 1S medical products. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,242.70 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide KEDRAB 300 UNIT/2 ML VIAL 2ML pharmaceutical products. This delivery order has a completion date of March 25, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,500 units of the medication KEDRAB 10 ML vial, with a total ceiling value of $1,626.70 and a period of performance through July 16, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp also holds a larger...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSCZ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $8,121.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 1,500 units of the pharmaceutical product KEDRAB (10 ml vials). The contract has a firm fixed-price pricing type and an ultimate completion date of July 11, 2024.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, the company provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the Department of Defense's medical treatment programs and facilities globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/17/24, 10:35 AM